|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06185 CANSINOBIO
Nominal 
51.800 +2.980 (+6.104%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 374,088 | 31.066% | 824,884 | 345,182 | 1,031,041 | 4,299,702 |
| Cost of Sales | (77,508) | -21.127% | (244,432) | (1,221,201) | (1,217,648) | (1,297,769) |
| Gross Profit | 296,580 | 58.471% | 580,452 | (876,019) | (186,607) | 3,001,933 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (12,357) | -12.119% | (15,152) | (15,046) | (8,777) | (1,824) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (944) | -94.172% | (16,768) | 1,217 | 0 | 0 | |
| Profit / (Loss) before Taxation | (19,303) | -91.578% | (381,204) | (1,978,884) | (1,184,001) | 1,936,787 | |
| Taxation | 5,818 | -- | (2,467) | 11,451 | 219,244 | (29,701) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 4,787 | 484,701 | 55,326 | 7,304 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (13,485) | -94.017% | (378,884) | (1,482,732) | (909,431) | 1,914,390 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 17,095 | -- | (22,186) | (56,298) | (184,741) | (25,175) |
| Depreciation & Amortisation | 83,724 | -26.876% | 213,662 | 271,476 | 229,962 | 99,417 |
| Directors' Emoluments | -- | -- | 15,148 | 21,816 | 26,049 | 22,831 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -5.000 | -94.505% | -153.000 | -601.000 | -368.000 | 774.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 80.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | 10.336% |
| Cash flow per share ($) | -- | -- | (0.684) | (3.713) | (7.641) | 8.141 |
| NBV per share ($) | 19.848 | -- | 19.874 | 21.316 | 27.271 | 32.310 |
| Remarks: | Real time quote last updated: 22/08/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -13,485 |
| %Change | -94.017% |
| EPS / (LPS) | RMB -0.050 |
| NBV Per Share (¥) | RMB 19.848 |